For pharma companies

Pakistan pharmaceutical market intelligence

1318 companies and 3966 molecules mapped from 2026-07-30 data. Opportunity scores combine brand crowding, price room versus official ceilings and regulatory exposure. Full company dashboards and category reports are available to pilot partners.

DRAPofficial ceilings & registrations
DVAGOobserved retail prices
Servaidobserved retail prices
DRAP alertsshortages & recalls

Top launch opportunities

MoleculeOpportunityBrandsCompaniesConfidence
Insulin Degludec7831100%
Sulfasalazine6842100%
Levonorgestrel664321100%
Estradiol632617100%
Acetylsalicylic Acid632611100%
Neostigmine621713100%
Medroxyprogesterone622114100%
Bevacizumab622713100%
Isosorbide Dinitrate612415100%
Hydralazine60114100%
Fluphenazine592619100%
Paracetamol581023358100%

Company profiles

Most crowded molecules

Ciprofloxacin1233 brands
Cefixime1027 brands
Paracetamol1023 brands
Azithromycin992 brands
Artemether985 brands
Levofloxacin889 brands
Omeprazole882 brands
Clarithromycin777 brands
Amlodipine710 brands
Ceftriaxone697 brands

Underserved molecules

Enflurane1 brands
Buflomedil1 brands
Beractant1 brands
Paramoxine1 brands
Para Aminobenzoic Acid1 brands
Halothane1 brands
Acebutolol1 brands
Hyaluronidase1 brands
Thioguanine1 brands
Mucoprotease1 brands

Want these packaged for your company?

We mapped categories across Pakistan — who competes, where the price room is, what’s crowded and what’s undersupplied. Category briefs and company profiles are the pilot package.

See intelligence reports Talk to us pilot pricing avail.

Data as of 2026-07-30 · schema v3-SKU · sources: drap_prices, drap_registry, dvago_alphabet, dvago_full, servaid, drap_alerts.

For medicine intelligence and professional reference only. Not medical advice.